Drivers
During the assessment period, the worldwide dental sleep medicine market is expected to rise at a significant CAGR (2016-2022). According to a Market Research Future (MRFR) analysis, some of the market trends and factors in this market include the rising global prevalence of sleep apnea, unmet medical needs, a growing geriatric population, adoption of cutting-edge innovative technologies, and an increase in the prevalence of lifestyle-related diseases such as cardiovascular disease and obesity.
Opportunities
In the projection period of 2021 to 2028, the dental sleep medicine market will benefit from increased research and development, as well as linked solutions and cloud-based systems, as well as personalized and customized solutions.
Restraints
Some factors that may impede the growth of the dental sleep medicine market include a lack of patient awareness and expensive treatment prices.
Challenges
The high cost and scarcity of sleep laboratories, as well as their lack of efficacy and efficiency, would restrict the expansion of the dental sleep medicine market, whereas inadequate standardization, lack of knowledge, and discomfort may provide a challenge to the dental sleep medicine market's growth.
Cumulative Growth Analysis
Unmet medical demands are driving the growth of the dental sleep medication industry. Obstructive sleep apnea affects over 30 million individuals in the United States, according to the American Academy of Dental Sleep Medicine. Sleep is harmed by sedentary lifestyles, extended working hours, noise exposure, and light pollution such as the usage of bright neon lights. Due to its safety, efficiency, and efficacy when compared to procedures and medicines, positive air pressure treatment has the greatest dental sleep medicine market share. The gold standard in dental sleep medicine diagnosis is polysomnography and respiratory polygraphy.
However, because of their simplicity of use, efficiency, and accuracy, the emergence of portable and home-based devices is threatening their market dominance. The primary reason for the increase in efficiency and accuracy is the employment of sophisticated software in these products. Oximetry is more portable and quicker, but the findings are less sensitive and accurate.
Value Chain Analysis
According to the reports, the global dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. Positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices are all part of the treatment section. Polysomnography and respiratory polygraphy, home oximetry, and actigraphy are all part of the diagnostics section. The dental sleep medicine market is divided into three categories based on the end-user hospitals, sleep labs, and homes.
In 2016, the treatment segment had the biggest dental sleep medicine global market share of 61.42 percent, and it is anticipated to increase at a CAGR of 8.74 percent from 2016 to 2022. In 2016, hospitals and sleep laboratories had the biggest dental sleep medicine global market share of 57.1 percent, while North America had the largest market share of USD 2,849.44 million.
The increasing recognition of the link between oral health and sleep disorders appears to drive a burgeoning interest in dental sleep medicine, suggesting a transformative shift in patient care and treatment approaches.
U.S. National Institutes of Health